Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Specimen Handling 641 pembrolizumab 585 Magnetic Resonance Spectroscopy 555 Carboplatin 431 Cyclophosphamide 381 Cisplatin 379 Biopsy 376 Nivolumab 315 Paclitaxel 314 Gemcitabine 308 Radiotherapy 286 Bevacizumab 235 Dexamethasone 218 fludarabine 206 Docetaxel 194 durvalumab 189 Oxaliplatin 189 venetoclax 187 Rituximab 175 Fluorouracil 175 atezolizumab 172 Pemetrexed 167 Capecitabine 164 Radiosurgery 162 Doxorubicin 162 Radiation 160 Ipilimumab 146 Lenalidomide 140 Leucovorin 138 Etoposide 134

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Registries × 90 days × Clear all

NCT03413982 2026-03-10

GUB-BCR-001

University of Kansas Medical Center

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡